JSPR:NASDAQJasper Therapeutics, Inc. analysis

Jasper Therapeutics, Inc. trades at $0.5697, with its short-term moving averages sitting below the longer-term ones — a bearish trend structure. It has lost 20.8% over the past 30 days. Momentum indicators put RSI at 42.1 (neutral) with MACD reading bearish. Price has been bracketed by support at $0.5400 and resistance at $0.7300.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 3410.6% above today's level.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 69.8%, a beta of 1.71 and a maximum drawdown of 86.9%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 3/10 conviction over the longer horizon.